Concepedia

Publication | Open Access

Posoleucel, an Allogeneic, Off-the-Shelf Multivirus-Specific T-Cell Therapy, for the Treatment of Refractory Viral Infections in the Post-HCT Setting

76

Citations

17

References

2023

Year

Abstract

In this open-label trial, treatment of refractory viral infections/disease in allo-HCT recipients with posoleucel was feasible, safe, and effective.

References

YearCitations

2009

771

2011

689

2007

637

2006

543

2017

439

2014

391

2002

363

1993

175

2017

169

2007

129

Page 1